// App-Quantinova.ai

: Bone Marrow Microenvironment Changes in Myelodysplastic Neoplasms and Its Relationship with Clonal Hematopoiesis and Disease Progression

Researchers

Presenter

  • Antonieta Molero Yordi

Principal Investigators

  • Laura Gallur

  • Barbara Tazon

  • Víctor Navarro Garcés

  • Silvia Saumell

  • Maria Julia Montoro

  • Olga Salamero

  • Ana Pérez González

  • Sara Garrido

  • Maria Sola

  • Tamara Jimenez

  • Félix López Cadenas

  • Teresa Ezponda

  • Ana Alfonso-Pierola

  • Lidia Altimiras

  • Maria Diez-Campelo

  • Felipe Prosper

  • David Valcarcel

Medical Centers

  • Department of Hematology. Salamanca-IBSAL university hospital, Salamanca, Spain

  • Department of Hematology, University Hospital Vall d'Hebron, University Autonoma of Barcelona (UAB), Barcelona, Spain

  • Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain

  • Department of Hematology, University Hospital Vall d'Hebron, University Autonoma of Barcelona (UAB), Experimental Hematology Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

  • Department of Hematology, University Hospital Vall d'Hebron, Experimental Hematology Unit, Vall d'Hebron Institute of Oncology (VHIO), University Autonoma of Barcelona (UAB), BARCELONA, Spain

  • Oncology Data Science (OdySsey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

  • Department of Oncology-Hematology, Centro de Investigación Médica Aplicada (CIMA), Navarra university-IDISNA. Centro de Investigación Biomédica en Red de Cáncer, CIBERONC. Clínica Universidad de Navarra, Pamplona, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Natural Killer cells

  • Cluster of Differentiation 14

  • Cluster of differentiation 45

  • Programmed death-ligand 1

  • Fc gamma RIIIa

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

  • Natural killer group 2D

  • NKp46

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A